Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123991072 | 12399107 | 2 | F | 20141028 | 20160715 | 20160524 | 20160726 | PER | US-PFIZER INC-2016272369 | PFIZER | 61.00 | YR | M | Y | 0.00000 | 20160726 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123991072 | 12399107 | 1 | PS | DEPO-TESTOSTERONE | TESTOSTERONE CYPIONATE | 1 | UNK, AS PRESCRIBED | U | 85635 | SOLUTION FOR INJECTION | |||||||||
| 123991072 | 12399107 | 2 | SS | TESTIM | TESTOSTERONE | 1 | UNK, AS PRESCRIBED | 0 | |||||||||||
| 123991072 | 12399107 | 3 | SS | ANDROGEL | TESTOSTERONE | 1 | UNK, AS PRESCRIBED | 0 | |||||||||||
| 123991072 | 12399107 | 4 | SS | TESTOSTERONE CYPIONATE. | TESTOSTERONE CYPIONATE | 1 | UNK, AS PRESCRIBED | U | 0 | ||||||||||
| 123991072 | 12399107 | 5 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 123991072 | 12399107 | 6 | C | OXYCODONE | OXYCODONE | 1 | UNK | 0 | |||||||||||
| 123991072 | 12399107 | 7 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 123991072 | 12399107 | 8 | C | BUPRENORPHINE. | BUPRENORPHINE | 1 | UNK | 0 | |||||||||||
| 123991072 | 12399107 | 9 | C | MELOXICAM. | MELOXICAM | 1 | UNK | 0 | |||||||||||
| 123991072 | 12399107 | 10 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | UNK | 0 | |||||||||||
| 123991072 | 12399107 | 11 | C | ENDOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123991072 | 12399107 | 1 | Hormone replacement therapy |
| 123991072 | 12399107 | 2 | Hormone replacement therapy |
| 123991072 | 12399107 | 3 | Hormone replacement therapy |
| 123991072 | 12399107 | 4 | Hormone replacement therapy |
| 123991072 | 12399107 | 5 | Anxiety |
| 123991072 | 12399107 | 6 | Pain |
| 123991072 | 12399107 | 7 | Urinary retention |
| 123991072 | 12399107 | 8 | Pain |
| 123991072 | 12399107 | 9 | Arthritis |
| 123991072 | 12399107 | 10 | Attention deficit/hyperactivity disorder |
| 123991072 | 12399107 | 11 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123991072 | 12399107 | OT |
| 123991072 | 12399107 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123991072 | 12399107 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123991072 | 12399107 | 1 | 201408 | 201501 | 0 | |
| 123991072 | 12399107 | 2 | 200910 | 201001 | 0 | |
| 123991072 | 12399107 | 3 | 201002 | 201005 | 0 | |
| 123991072 | 12399107 | 4 | 201310 | 201503 | 0 | |
| 123991072 | 12399107 | 5 | 2011 | 0 | ||
| 123991072 | 12399107 | 6 | 2011 | 0 | ||
| 123991072 | 12399107 | 7 | 2012 | 0 | ||
| 123991072 | 12399107 | 8 | 2012 | 0 | ||
| 123991072 | 12399107 | 9 | 201204 | 201501 | 0 | |
| 123991072 | 12399107 | 10 | 2013 | 0 | ||
| 123991072 | 12399107 | 11 | 201405 | 201501 | 0 |